Literature DB >> 17415141

Expressions of aquaporin-2, vasopressin type 2 receptor, transient receptor potential channel vanilloid (TRPV)1, and TRPV4 in the human endolymphatic sac.

Daizo Taguchi1, Taizo Takeda, Akinobu Kakigi, Masaya Takumida, Rie Nishioka, Hiroya Kitano.   

Abstract

OBJECTIVE: To localize aquaporin (AQP)2, vasopressin type 2 receptor (V2-R), and transient receptor potential channel vanilloid subfamily 1, 4 (TRPV1, TRPV4) in the human endolymphatic sac (ES).
METHODS: Three samples of human ES were sampled during the removal of vestibular schwannoma by way of the translabyrinthine approach. The samples were immediately fixed in 4% paraformaldehyde and embedded in OCT compound; immunohistochemistry was performed with AQP2, V2-R, TRPV1, and TRPV4 polyclonal antibodies.
RESULTS: AQP2, V2-R, TRPV1, and TRPV4 proteins were detected in the epithelial layer of the ES but were not observed in connective tissue around the ES. TRPV1 was also expressed in blood vascular endothelial cells of the connective tissue of ES.
CONCLUSIONS: AQP2, V2-R, and TRPV4 were expressed in the luminal epithelium of human ES. The same characteristic distribution of water and ion channels is seen in the kidney, where a significant amount of fluid is filtrated and resorbed. ES probably plays an active role in the homeostasis of the endolymph.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17415141     DOI: 10.1097/mlg.0b013e318031c802

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  Advances in Auditory and Vestibular Medicine.

Authors:  Mohamed A Hamid; Dennis R Trune; Mayank B Dutia
Journal:  Audiol Med       Date:  2009-12-01

Review 2.  Issues, indications, and controversies regarding intratympanic steroid perfusion.

Authors:  Mohamed Hamid; Dennis Trune
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 2.064

Review 3.  Aquaporin water channels in mammals.

Authors:  Kenichi Ishibashi; Shigeki Hara; Shintaro Kondo
Journal:  Clin Exp Nephrol       Date:  2008-12-16       Impact factor: 2.801

Review 4.  Mechanisms of otoconia and otolith development.

Authors:  Yunxia Wang Lundberg; Yinfang Xu; Kevin D Thiessen; Kenneth L Kramer
Journal:  Dev Dyn       Date:  2014-10-18       Impact factor: 3.780

5.  Non-contrast MRI of Inner Ear Detected Differences of Endolymphatic Drainage System Between Vestibular Migraine and Unilateral Ménière's Disease.

Authors:  Yangming Leng; Ping Lei; Cen Chen; Yingzhao Liu; Kaijun Xia; Bo Liu
Journal:  Front Neurol       Date:  2022-04-29       Impact factor: 4.003

Review 6.  Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere's disease.

Authors:  Nozomu Mori; Takenori Miyashita; Ryuhei Inamoto; Ai Matsubara; Terushige Mori; Kosuke Akiyama; Hiroshi Hoshikawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-01       Impact factor: 2.503

7.  Claudin expression in the rat endolymphatic duct and sac - first insights into regulation of the paracellular barrier by vasopressin.

Authors:  Daniel Runggaldier; Lidia Garcia Pradas; Peter H Neckel; Andreas F Mack; Bernhard Hirt; Corinna Gleiser
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

8.  Autoinflammatory characteristics and short-term effects of delivering high-dose steroids to the surface of the intact endolymphatic sac and incus in refractory Ménière's disease.

Authors:  Jing Zou
Journal:  J Otol       Date:  2019-01-06

9.  Changes to Zonular Tension Alters the Subcellular Distribution of AQP5 in Regions of Influx and Efflux of Water in the Rat Lens.

Authors:  Rosica S Petrova; Nandini Bavana; Rusin Zhao; Kevin L Schey; Paul J Donaldson
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

10.  Simultaneous Presentation of Definite Vestibular Migraine and Definite Ménière's Disease: Overlapping Syndrome of Two Diseases.

Authors:  Toshihisa Murofushi; Masahito Tsubota; Kyoko Kitao; Eriko Yoshimura
Journal:  Front Neurol       Date:  2018-09-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.